Point Of Care Diagnostics Market Shares, Strategy, and Forecasts, Worldwide Report 2030

 The global point of care diagnostics market size is expected to reach USD 68.5 billion by 2030, registering a CAGR of 6.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The introduction of advanced technologies such as Telehealth enabled POCT is expected to fuel market growth. Furthermore, the rise in the geriatric population and their need for accessible home-based care are anticipated to drive the market.

The adoption of POCT in emerging economies such as Africa and Latin America is anticipated to be a growth determinant of the global POCT market. The authorities are decentralizing the healthcare system and increasing their investments. For instance, the African regulations in Kenya allotted USD 346.7 to Managed Equipment Services project for the government's initiative toward modernizing facilities by procuring new equipment. The Ministry of Health selected GE Health and Philips to offer equipment across 47 countries. Similarly, Latin America decentralized IVD testing, which encourages private players to take strategic initiatives to meet the region’s existing demand for affordable POCT, especially in the infectious diseases segment.

Gather more insights about the market drivers, restrains and growth of the Global Point Of Care Diagnostics Market

Currently developed POC devices and tests are employed across different medical diagnostic applications, including cancer, pregnancy, and infectious diseases. Patients and physicians employ POC tests to screen conditions, confirm diagnoses, and design suitable therapeutic approaches based on patient health. However, the enthusiasm displayed by different consumers, such as doctors, patients, and caregivers, varies widely. This dynamic consumption pattern of POC diagnostic products is also attributed to economic scalability, financial interests, and lack of a universal healthcare structure.

Point Of Care Diagnostics Market Report Highlights

• The Infectious disease led the market and accounted for 27.8% of global revenue share in 2023. Growth of the segment is attributed to increasing demand for rapid tests, which has encouraged industry players to deliver point of care solutions to decentralized regions and launch innovative solutions.
• Home sector is projected to witness the highest growth rate over the forecast period owing to the comfort level and cost-effectiveness of point of care diagnostics provided to patients at home. POCT devices are easy to use and do not, mandatorily, require any modern lab infrastructure for testing simpler target analytes in a patient's sample
• North America dominated the market and accounted for a 42.9% share in 2023 owing to the increasing demand for new technologies, a large pool of key players, and advanced healthcare infrastructure
• The Asia Pacific is anticipated to witness significant growth in the market owing to the rising prevalence of cancer, diabetes, cardiovascular diseases, and infectious diseases. The increasing population with limited disposable income is the potential target market for the key players in the region

Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.

• Multi Cancer Early Detection Market: The global multi cancer early detection market size was estimated at USD 1.12 billion in 2024 and is projected to grow at a CAGR of 17% from 2025 to 2030.
• Proteinase K Market: The global proteinase K market size was estimated at USD 4.78 billion in 2024 and is expected to grow at a CAGR of 8.5% from 2025 to 2030.

Point Of Care Diagnostics Market Segmentation

Grand View Research has segmented the global point of care diagnostics market on the basis of on product, end use, and region:

Point Of Care Diagnostics Product Outlook (Revenue, USD Billion, 2018 - 2030)

• Glucose Testing
• Hb1Ac Testing
• Coagulation Testing
• Fertility/Pregnancy
• Infectious Disease
  • HIV POC
  • Clostridium Difficile POC
  • HBV POC
  • Pneumonia or Streptococcus Associated Infections
  • Respiratory Syncytial Virus (RSV) POC
  • HPV POC
  • Influenza/Flu POC
  • HCV POC
  • MRSA POC
  • TB and Drug-resistant TB POC
  • HSV POC
  • COVID-19
  • Other Infectious Diseases
• Cardiac Markers
• Thyroid Stimulating Hormone
• Hematology
• Primary Care Systems
• Decentralized Clinical Chemistry
• Feces
• Lipid Testing
• Cancer Marker
• Blood Gas/Electrolytes
• Ambulatory Chemistry
• Drug of Abuse (DOA) Testing
• Autoimmune Diseases
• Urinalysis/Nephrology

Point Of Care Diagnostics End-use Outlook (Revenue, USD Billion, 2018 - 2030)

• Clinics
• Hospitals
• Home
• Assisted Living Healthcare Facilities
• Laboratory

Point Of Care Diagnostics Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)

Order a free sample PDF of the Point Of Care Diagnostics Market Intelligence Study, published by Grand View Research.

Medical Device Outsourcing Market Growth, Scope, Demand and Global Outlook by 2030

 The global medical device outsourcing market size is expected to reach USD 292.9 billion by 2030, at a CAGR of 12.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising demand for advanced medical products and a growing trend of offshoring is fueling the medical device outsourcing market growth.

Regulatory bodies are emphasizing the quality of the healthcare devices provided to the public which is becoming burdensome to handle. To meet the regulatory scenario, various services like regulatory consulting are being utilized by the industry players. For example, the European Medical Device Regulation undertakes special spontaneous inspection of outsourced products to test the quality as well as conformity with standards.

Gather more insights about the market drivers, restrains and growth of the Global Medical Device Outsourcing Market

Contract manufacturers, especially in developed countries like the U.S., EU nations, and Japan, comply with the international standard for the quality management system, which makes them a preferred option as compared with contract manufacturers in India and China. However, regulatory changes anticipated in developing countries ensure compliance by contract manufacturers. Demand for regulatory compliance is expected to boost the growth of consulting services such as remediation, compliance, and QMS, thereby contributing to the growth of the global medical device outsourcing market.

Owing to COVID-19, there was a decline in the number of diagnoses for other diseases like cancer and tuberculosis among others. The recovery from COVID-19 is expected to increase demand for the medical devices used for diagnosing these diseases. Public organizations across the globe are taking initiatives to increase the production of medical equipment to prevent a future shortage. For instance, in January 2021, U.S. president Joseph Biden in response to the pandemic preparedness emphasized improving gaps in the supply chain by augmenting domestic manufacturing of test kits, PPE, and durable medical equipment.

Medical Device Outsourcing Market Report Highlights

• The contract manufacturing market dominated the market with a share of 54.4% in 2023 owing to the growing trend of outsourcing by OEM to third-party manufacturers, especially in emerging countries
• The cardiology segment dominated the application segment with a market share of 21% in 2023. Rising demand for cardiovascular devices as a result of the increasing prevalence of associated conditions is attributed to the growth of outsourcing of these devices
• The Class II segment dominated the class type market and accounted for 81.34% in 2023. The key factors contributing to the growth of the segment are the majority of the devices almost 43.0% fall under this category and the cost of medical devices is also high
• Asia Pacific region dominated the global market in 2022 with a share of 41.3% owing to lower cost and availability of skilled human resources.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• High Pressure Balloon Catheter Market: The global high pressure balloon catheter market size was estimated at USD 3.03 billion in 2024 and is anticipated to grow at a CAGR of 8.90% from 2025 to 2030.
• Wearable Artificial Kidney Market: The global wearable artificial kidney market size was valued at USD 575.5 million in 2024 and is anticipated to grow at a CAGR of 6.9% from 2025 to 2030.

Medical Device Outsourcing Market Segmentation

Grand View Research has segmented the global medical device outsourcing market based on the service, application, class, and region.

Medical Device Outsourcing Service Outlook (Revenue, USD Million, 2018 - 2030)

• Quality Assurance
• Regulatory Affairs Services
  • Clinical Trials Applications & Product Registrations
  • Regulatory Writing & Publishing
  • Legal Representation
  • Others
• Product Design & Development Services
  • Designing & Engineering
  • Machining
  • Molding
  • Packaging
• Product Testing & Sterilization Services
• Product Implementation Services
• Product Upgrade Services
• Product Maintenance Services
• Contract Manufacturing
  • Accessories Manufacturing
  • Assembly Manufacturing
  • Component Manufacturing
  • Device Manufacturing

Medical Device Outsourcing Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cardiology
• Diagnostic Imaging
• Orthopedic
• IVD
• Ophthalmic
• General & Plastic Surgery
• Drug Delivery
• Dental
• Endoscopy
• Diabetes Care
• Others

Medical Device Outsourcing Class Outlook (Revenue, USD Million, 2018 - 2030)

• Class I
• Class II
• Class III

Medical Device Outsourcing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • Sweden
  • Belgium
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Indonesia
  • Malaysia
  • Singapore
  • South Korea
  • Thailand
  • Taiwan
  • Australia
  • Philippines
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Egypt

Order a free sample PDF of the Medical Device Outsourcing Market Intelligence Study, published by Grand View Research.

Life Science Tools Market To Deliver Prominent Growth & Striking Opportunities

 The global life science tools market size is expected to reach USD 330.69 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.8% from 2023 to 2030. This growth can be attributed to a rise in government funding for life science technologies, demand for cell and gene therapies, an increase in the adoption of biopharmaceuticals, and growing competition among prominent companies in the market.

The exponential rise of COVID-19 cases globally requires rapid diagnosis for containment of the spread of infectious disease, which boosted the demand for life science tools during the pandemic and had a positive impact on the market. Rapid diagnosis of the infection, effective treatments, and preventative plans are essential for the management of cases during the COVID-19 pandemic. The current race for the development of cost-effective point-of-contact test kits and efficient laboratory methodologies for confirmation of SARS-CoV-2 infection has driven a new frontier of diagnostic innovation. During this pandemic, the U.S. FDA granted Emergency Use Authorizations (EUAs) to several diagnostic tests to make them rapidly and easily available for use. For example, in May 2022, the U.S. FDA granted a EUA to ID NOW COVID-19 2.0, a rapid in-vitro diagnostic test by Abbott Diagnostics Scarborough, Inc. Moreover, a wide range of commercial COVID-19 tests is available in the marketplace, which will further add to revenue generation.

Gather more insights about the market drivers, restrains and growth of the Global Life Science Tools Market

Additionally, the life science tools industry is expanding based on the increasing investments by the government for the advancement of research and technologies. Organizations such as The National Human Genome Research Institute (NHGRI) and the National Institutes of Health (NIH) are actively funding various life science projects. For instance, the NIH funded USD 25 million for the ‘4D Nucleome Program’, which aims to understand gene regulation and cellular expression via the nuclear organization. Moreover, the U.S. government has funded several life sciences companies for R&D purposes. For instance, the Biomedical Advanced Research and Development Authority (BARDA) has planned to make awards worth USD 750,000 to facilitate the development of innovative technologies in the healthcare sector. Thus, the increase in government funding for life science research as well as technologies is expected to drive the market in the coming years.

Life Science Tools Market Report Highlights

• By technology, cell biology technology accounted for the largest share in 2022. The introduction of novel technologies for the usage and adoption of stem cells, CAR T-cells, TCR T-cells, NK T-cells, and other cell therapies is expected to boost revenue generation in this segment
• By product, the cell culture systems and 3D cell culture segment held the largest share in 2022. Cell biology is gaining popularity across multiple aspects in the life science industry, which is contributing significantly to the revenue generated by this segment
• By end-use, the healthcare segment generated the highest revenue in 2022. The rise in adoption of proteomic and genomic workflows in clinics, hospitals, and diagnostic laboratories for the treatment and diagnosis of several clinically presented abnormalities is anticipated to drive the market
• North America accounted for the largest revenue share in 2022. The rapid adoption of genomics, proteomics, oncology, and diagnostic screening in the region has contributed to regional growth. In addition, a number of major market players are continuously engaged in the development of advanced tools for life science research in this region
• Asia Pacific is expected to grow at the highest rate over the projected period. Investments by global companies in this region to utilize the untapped avenue and lucrative opportunities will drive the regional market

Browse through Grand View Research's Biotechnology Industry Research Reports.

• Next-generation Sequencing Data Analysis Market: The global next-generation sequencing data analysis market size was valued at USD 999.4 million in 2024 and is expected to expand at a CAGR of 23.10% from 2025 to 2030.
• Stem Cell Therapy Market: The global stem cell therapy market size was estimated at USD 456.0 million in 2024 and is expected to grow at a CAGR of 25.23% from 2025 to 2030.

Life Science Tools Market Segmentation

Grand View Research has segmented the global life science tools market on the basis of technology, product, end-use, and region:

Life Science Tools Technology Outlook (Revenue, USD Billion, 2018 - 2030)

• Genomic Technology
• Proteomics Technology
• Cell Biology Technology
• Other Analytical & Sample Preparation Technology
• Lab Supplies & Technologies

Life Science Tools Product Outlook (Revenue, USD Billion, 2018 - 2030)

• Cell Culture Systems & 3D Cell Culture
• Liquid Chromatography
• Mass Spectrometry
• Flow Cytometry
• Cloning & Genome Engineering
• Microscopy & Electron Microscopy
• Next Generation Sequencing
• PCR & qPCR
• Nucleic Acid Preparation
• Nucleic Acid Microarray
• Sanger Sequencing
• Transfection Devices & Gene Delivery Technologies
• NMR
• Other Separation Technologies
• Other Products & Services

Life Science Tools End-use Outlook (Revenue, USD Billion, 2018 - 2030)

• Government & Academic
• Biopharmaceutical Company
• Healthcare
• Industrial Applications
• Others

Life Science Tools Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Order a free sample PDF of the Life Science Tools Market Intelligence Study, published by Grand View Research.

Facial Injectable Market Growth Drivers With Outlook And Opportunity Forecast To 2030

 The global facial injectable market size is expected to reach USD 24.92 billion by 2030, registering a CAGR of 12.0% from 2023 to 2030, according to a new report by Grand View Research, Inc. The facial injectables are crucial in anti-aging treatments and are particularly used to stop damage such as hyperpigmentation and early aging. The most popular treatments across all socioeconomic groups are Botox and fillers, which have gained immense popularity.

Growing focus on physical appearance, especially in developing countries is one of the key factors expected to drive the market. In addition, a shift in consumer preference towards minimally invasive procedures is also expected to support market growth. According to the American Society of Plastic Surgeons (ASPS), in 2020, botulinum toxin A and soft tissue fillers were among the top 5 minimally invasive procedures carried out in the U.S. Thus, facial injectable holds high growth prospects in the years to come.

The onset of the pandemic led to nonurgent and cosmetic surgeries being put on hold in the first and second quarters of 2020. Since there were stringent restrictions imposed by the authority bodies as a precaution, the coronavirus outbreak has had an impact on every industry, including the cosmetics industry. Aesthetics-related product supply chains were also impacted. The demand-supply chain across the whole medical device sector has been severely disrupted by the pandemic.

Gather more insights about the market drivers, restrains and growth of the Global Facial Injectable Market

Facial Injectable Market Report Highlights

• Based on product, the botulinum toxin type A segment is projected to dominate the market throughout the forecast period. It is one of the most popularly used minimally invasive procedures
• Based on application, the facial line correction segment dominated the market and accounted for the largest revenue share of 33.2% in 2022. This growth is owing to the increasing use of facial injectables for aesthetic procedures such as facial lines, wrinkles on the face, and lip lines
• Based on end-use, the medSpa segment dominated the market and held the largest revenue share of 46.8% in 2022. All noninvasive treatments are performed in these facilities, which include facial injections, non-invasive body contouring, skin rejuvenation, and laser treatments by experienced professionals
• North America dominated the market with a revenue share of 39.7% in 2022 owing to the easy availability of the products and the presence of a large number of skilled surgeons
• The Asia Pacific region is expected to serve as a key revenue-generating center. The region is backed by countries such as India, where a growing focus on physical appearance is expected to create a lucrative opportunity for the market

Browse through Grand View Research's Medical Devices Industry Research Reports.

• High Pressure Balloon Catheter Market: The global high pressure balloon catheter market size was estimated at USD 3.03 billion in 2024 and is anticipated to grow at a CAGR of 8.90% from 2025 to 2030
• Non-invasive Coronary Imaging Market: The global non-invasive coronary imaging market size was estimated at USD 404.3 million in 2024 and is expected to grow at a CAGR of 6.6% from 2025 to 2030.

Facial Injectable Market Segmentation

Grand View Research has segmented the global facial injectable market based on product, application, end-use, and region:

Facial Injectable Product Outlook (Revenue, USD Billion, 2018 - 2030)

• Collagen & PMMA Microspheres
• Hyaluronic Acid (HA)
• Botulinum Toxin Type A
• Calcium Hydroxylapatite (CaHA)
• Poly-L-lactic Acid (PLLA)
• Others

Facial Injectable Application Outlook (Revenue, USD Billion, 2018 - 2030)

• Facial Line Correction
• Lip Augmentation
• Face Lift
• Acne Scar Treatment
• Lipoatrophy Treatment
• Others

Facial Injectable End-use Outlook (Revenue, USD Billion, 2018 - 2030)

• MedSpas
• Dermatology Clinics
• Hospitals

Facial Injectable Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Order a free sample PDF of the Facial Injectable Market Intelligence Study, published by Grand View Research.

Biopharmaceutical CMO And CRO Market expected to show significant growth over the forecast period

 The global biopharmaceutical CMO and CRO market was valued at USD 54.12 billion in 2030 and is anticipated to grow at a CAGR of 5.6% from 2024 to 2030 according to a new study by Grand View Research, Inc. Post-pandemic the market is being driven by the growing interest of conventional drug developers in the biological therapeutics. At present, outsourcing has become a cost-saving strategy for small- to medium-sized biomanufacturers, as it helps in eliminating the need for establishing costly specialized facilities or hiring and training personnel. The post-pandemic recovery has started owing to positive pipeline developments across modalities.

For instance, Lonza and Moderna announced a ten-year collaboration for the commercial manufacturing of the COVID-19 vaccine. Such developments compensated for minor delays in clinical trials that occurred during the first half of 2020. The contract manufacturing organization segment is projected to unlock lucrative growth opportunities over the foreseeable future. The decline in R&D productivity and increased development costs have resulted in high pressure on biopharmaceutical manufacturers pertaining to short-term earnings and profit margins. This, in turn, has created lucrative opportunities for the CMOs & CROs to accelerate their business operations.

The robustness of venture capital investments is one of the important supportive factors that has created opportunities for the growth of CMOs. Venture capital funds are considered more reliable than public equity. An increase in the availability of venture funds for life sciences is expected to bolster the growth of CMOs. However, these CMOs & CROs are expected to face competition from in-house departments of pharmaceutical & biotechnology companies. Several big pharma companies like Novartis announced to maintain and expand their biomanufacturing processes in-house over the coming years.

Gather more insights about the market drivers, restrains and growth of the Global Biopharmaceutical CMO And CRO Market

Biopharmaceutical CMO And CRO Market Report Highlights

• Non-mammalian cell line-based bioproduction system is expected to be the fastest-growing segment over the forecast period
• Innovative strategies are being implemented to identify and explore the potential of various microbe
• This can be attributed to increasing investments in research programs for the development of novel therapeutics
• The market in North America is recognized as a leader in biopharmaceutical innovations, thereby resulting in a large share of 33.9%
• Moreover, the presence of several service providers and a higher concentration & number of biopharmaceutical firms in the region supports the market growth
• The key players are involved in establishing mutually beneficial alliances with other emerging CMOs to scale up their production capabilities

Browse through Grand View Research's Medical Devices Industry Research Reports.

• Tracheostomy Products Market: The global tracheostomy products market size was estimated at USD 216.9 million in 2024 and is expected to grow at a CAGR of 4.3% from 2025 to 2030.
• Oral Syringes Market: The global oral syringes market size was valued at USD 742.5 million in 2024 and is expected to grow a CAGR of 6.1% from 2025 to 2030.

Biopharmaceutical CMO And CRO Market Segmentation

Grand View Research has segmented the global biopharmaceutical CMO & CRO Market report on the basis of source, service, product, and region:

Biopharmaceutical CMO And CRO Source Outlook (Revenue, USD Billion, 2018 - 2030)

• Mammalian
• Non-mammalian

Biopharmaceutical CMO And CRO Service Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Contract Manufacturing
  • Process Development
  • Fill & Finish Operations
  • Analytical & QC Studies
  • Packaging
• Contract Research
  • Oncology
  • Inflammation & Immunology
  • Cardiology
  • Neuroscience
  • Others

Biopharmaceutical CMO And CRO Product Outlook (Revenue, USD Billion, 2018 - 2030)

• Biologics
  • Monoclonal antibodies (MAbs)
  • Recombinant Proteins
  • Vaccines
  • Antisense, RNAi, & Molecular Therapy
  • Others
• Biosimilars

Biopharmaceutical CMO And CRO Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Sweden
  • Norway
  • Denmark
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Order a free sample PDF of the Biopharmaceutical CMO And CRO Market Intelligence Study, published by Grand View Research.

Wound Care Market set to Witness Rapid Growth by 2030

 The global wound care market is anticipated to reach USD 29.57 billion by 2030, growing at a CAGR of 4.19% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing number of surgical cases, a rapidly aging population, as well as a rising number of diabetic patients, are among the major factors driving this market’s growth. For instance, according to Ageing Asia, as of 2019, more than 139 million people, i.e., about 10% of India’s total population, were over 60. This is expected to increase up to 19.5% in 2050. The geriatric population is more susceptible to wounds, and thus, increasing the number of elder populations, the wound care market is anticipated to propel during the forecast period.

The wound care market has seen significant technological advancements in recent years, leading to the development of new and innovative products for treating various types of wounds. Growth factors are naturally occurring proteins that stimulate cell growth and division. These proteins can be used in wound care to promote healing and tissue regeneration. For example, platelet-derived growth factor (PDGF) is effective in promoting the healing of chronic wounds. 3D printing technology has revolutionized the production of custom-made wound care products, such as prosthetic limbs, orthotics, and wound dressings.

Gather more insights about the market drivers, restrains and growth of the Global Wound Care Market

In addition, many leading manufacturers are undergoing strategic initiatives such as product launches, partnerships, and geographic expansion, which may help them capitalize on the increasing demand for wound care products during the forecast period. For instance, Human Biosciences planned on launching two new wound care products in the Indian market. The launch of these products in the Indian market is expected to help the company capture the post-pandemic wound care market in India. Thus, similar initiatives by other market players are anticipated to boost the wound care market post-pandemic.

Wound Care Market Report Highlights

• Based on product, advanced wound dressing dominated the wound care market with a share of 34.9% in 2024, owing to the advantages offered by these dressings over traditional.
• Based on application, the chronic wound segment will likely dominate the wound care market with a market share of 59.9% in 2024, owing to increased diabetic foot ulcers and pressure ulcers worldwide.
• Based on end-use, the hospital segment dominated the wound care market, owing to the increasing number of surgical site infections among hospital patients. On the other hand, the home healthcare segment is anticipated to witness the fastest growth in the forecast period.
• Based on the mode of purchase, the prescribed segment dominated the wound care market, with a share of 62.8% in 2024.
• Based on the distribution channel, the institutional sales segment dominated the market. However, the retail sales segment is anticipated to witness the fastest growth, with a CAGR of 4.6% over the forecast period.
• North America dominated the wound care market with the highest revenue share of 45.5% in 2024 owing to the increasing number of surgical procedures and technological advancements.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• Synoptophore Market: The global synoptophore market was estimated at USD 256.1 million in 2024 and is projected to grow at a CAGR of 6.9% from 2025 to 2030.
• 3D Medical Imaging Devices Market: The global 3D medical imaging devices market size was estimated at USD 12.74 billion in 2024 and is expected to expand at a CAGR of 8.11% from 2025 to 2030.

Wound Care Market Segmentation

Grand View Research has segmented the global wound care market report on the basis of product, application, end-use, mode of purchase, distribution channel and region:

Wound Care Product Outlook (Revenue, USD Million, 2018 - 2030)

• Advanced Wound Dressing
  • Foam Dressings
  • Hydrocolloid Dressings
  • Film Dressings
  • Alginate Dressings
  • Hydrogel Dressings
  • Collagen Dressings
  • Other Advanced Dressings
• Surgical Wound Care
  • Sutures & staples
  • Tissue adhesive and sealants
  • Anti-infective dressing
• Traditional Wound Care
  • Medical Tapes
  • Cotton
  • Bandages
  • Gauzes
  • Sponges
  • Cleansing Agents
• Wound Therapy Devices
  • Negative pressure wound therapy
  • Oxygen and hyperbaric oxygen equipment
  • Electric stimulation devices
  • Pressure relief devices
  • Others

Wound Care Application Outlook (Revenue, USD Million, 2018 - 2030)

• Chronic Wounds
  • Diabetic foot ulcers
  • Pressure ulcers
  • Venous leg ulcers
  • Other chronic wounds
• Acute Wounds
  • Surgical & traumatic wounds
  • Burns

Wound Care End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Specialty Clinics
• Home Healthcare
• Physician’s Office
• Nursing Homes
• Others

Wound Care Mode Of Purchase Outlook (Revenue, USD Million, 2018 - 2030)

• Prescribed
• Non-prescribed (OTC)

Wound Care Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Institutional Sales
• Retail Sales

Wound Care Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Order a free sample PDF of the Wound Care Market Intelligence Study, published by Grand View Research.

Smart Agriculture Market Size, Share & Trends Analysis Report By 2030

 The global smart agriculture market size is expected to reach USD 54.71 billion by 2030, registering a CAGR of 13.7% during the forecast period, according to a new report by Grand View Research, Inc. The major factors driving the growth of the agtech industry are the increasing use of Artificial Intelligence (AI) and Internet of Things (IoT) and the integration of image processing technologies into agriculture. Agriculture has grown significantly in recent years owing to precision agriculture practices. The development plan of several nations, such as India, China, and Brazil, emphasizes digital transformation and digitization across various sectors, including agriculture.

The smart agriculture business is predicted to be driven by factors such as constant population increase, favourable government incentives, a scarcity of cultivable land, and a desire for high and fresh-quality food. According to World Health Organization (WHO) and Population Council, an estimated 80% of the world's population lives in urban cities. However, the current land constraint in metropolitan areas has compelled producers to find a new way to produce fresh vegetables. The adoption of smart agriculture techniques will allow producers to grow crops indoors, in a multi-story building, stacked on racks, and in warehouse.

Gather more insights about the market drivers, restrains and growth of the Global Smart Agriculture Market

Smart farming can be utilized to produce organic crops on a vast scale. Vertical farming can be used in the large-scale production of organic crops. Controlled growing technologies such as hydroponics and aeroponics eliminate the use of chemical pesticides. Crops are produced in carefully chosen and well-monitored circumstances to guarantee optimal growth all year. As compared to open-field agriculture and other farming practices, vertical farm systems provide more crop rotation. Controlled humidity, temperature, and daylight will eventually result in a faster crop cycle. It takes 21 days for the system to produce fresh vegetables and greens. The growth rate is controlled with the help of a computer database that manages optimum growing conditions for various varieties such as baby spinach, lettuces, baby rocket, tatsoi, and basil.

Technological improvements in numerous industries have also positively impacted agriculture, as landowners and farmers are always striving to get the most out of their resources and land. Furthermore, due to labor difficulties such as a shortage of qualified farmers, a rising number of aged farmers, and a growing trend of large-scale farms, agriculture automation is gaining pace. Innovations in GPS mapping and associated farm applications, as well as advancements in precision agriculture, are also assisting farmers in operating more effectively and increasing their profit margins.

Smart Agriculture Market Report Highlights

• Precision farming agriculture type held the significant market share in 2023 as it allows measured application of agriculture inputs such as fertilizers and pesticides, thereby boosting the crop yield
• The software segment is expected to register the highest growth rate over the forecast period. Cloud-based software is expected to be in high demand in the coming years
• Smart greenhouse application is expected to be the fastest-growing segment during the forecast period of 2024 to 2030. HVAC management applications held the largest share in terms of revenue in 2023
• The increasing adoption of modern technologies in agriculture, along with the reduced price of connected devices, is likely to influence the demand for smart agriculture solutions in the Asia Pacific regional market.

Browse through Grand View Research's Next Generation Technologies Industry Research Reports.

• Satellite Propulsion System Market: The global satellite propulsion system market size was estimated at USD 11.05 billion in 2024 and is projected to grow at a CAGR of 13.6% from 2025 to 2030.
• AI In Cybersecurity Market: The global AI in cybersecurity market size was estimated at USD 25.35 billion in 2024 and is expected to witness a CAGR of 24.4% from 2025 to 2030.

Smart Agriculture Market Segmentation

Grand View Research has segmented the Smart Agriculture market based on offering, application, and regions

Smart Agriculture Type Outlook (Revenue, USD Million, 2017 - 2030)

• Precision farming
• Livestock monitoring
• Smart greenhouse
• Others

Smart Agriculture Offering Outlook (Revenue, USD Million, 2017 - 2030)

• Hardware
  • Automation & control systems
  • Sensing devices
  • HVAC system
  • LED grow light
  • RFID tags & readers
• Software
  • Web-based
  • Cloud-based
• Types
  • System integration & consulting
  • Maintenance & support
  • Managed types
  • Assisted professional types

Smart Agriculture Application Outlook (Revenue, USD Million; 2017 - 2030)

• Precision farming application
  • Yield monitoring
  • Field mapping
  • Crop scouting
  • Weather tracking & forecasting
  • Irrigation management
  • Inventory management
  • Farm labor management
• Livestock monitoring application
  • Milk harvesting
  • Breeding management
  • Feeding management
  • Animal comfort management
  • Others
• Smart greenhouse application
  • Water & fertilizer management
  • HVAC management
  • Yield monitoring
  • Others
• Others

Smart Agriculture Regional Outlook (Revenue, USD Billion, 2017 - 2030)

• North America
• Europe
• Asia Pacific
• South America
• Middle East and Africa (MEA)

Order a free sample PDF of the Smart Agriculture Market Intelligence Study, published by Grand View Research.